Erratum: Expression of concern (Evidence for markers of hypoxia and apoptosis in explanted human carotid atherosclerotic plaques (2010) 52(4) (1015–1021), (S0741521410013443), (10.1016/j.jvs.2010.05.116));Evidence for markers of hypoxia and apoptosis in explanted human carotid atherosclerotic plaques

Journal of Vascular Surgery

Volumn 52, Issue 4, 2010, Pages 1015-1021

  Bitto, Alessandra ^a   De Caridi, Giovanni ^a   Polito, Francesca ^a   Cal, Margherita ^b   Irrera, Natasha ^a   Altavilla, Domenica ^a   Spinelli, Francesco ^a   Squadrito, Francesco ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; CASPASE 9; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOCLAST DIFFERENTIATION FACTOR; STRESS ACTIVATED PROTEIN KINASE; AUTACOID; BIOLOGICAL MARKER; CASP9 PROTEIN, HUMAN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HIF1A PROTEIN, HUMAN; INDUCIBLE NITRIC OXIDE SYNTHASE; MAP3K5 PROTEIN, HUMAN; NOS2 PROTEIN, HUMAN; NOS3 PROTEIN, HUMAN; OSTEOPROTEGERIN; TNFRSF11B PROTEIN, HUMAN; TNFSF11 PROTEIN, HUMAN;

AGED; ANGIOPLASTY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL FUNCTION; CLINICAL ARTICLE; HISTOLOGY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; APOPTOSIS; CAROTID ARTERY; CAROTID ARTERY DISEASES; CASE CONTROL STUDY; CELL HYPOXIA; CHEMISTRY; FINLAND; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PHOSPHORYLATION; UPREGULATION;

ANGIOPLASTY; APOPTOSIS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CASE-CONTROL STUDIES; CASPASE 9; CELL HYPOXIA; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FINLAND; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE KINASE 5; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; OSTEOPROTEGERIN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RANK LIGAND; UP-REGULATION;

EID: 77957578097     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2022.06.084     Document Type: Erratum

References (25)

1. D. Steinberg, and A. Lewis Conner Memorial Lecture Oxidative modification of LDL and atherogenesis Circulation 95 1997 1062 1071
2. I. Tabas Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency Arterioscler Thromb Vasc Biol 25 2005 2255 2264
3. D.M. Schrijvers, G.R. De Meyer, A.G. Herman, and W. Martinet Phagocytosis in atherosclerosis: molecular mechanisms and implications for plaque progression and stability Cardiovasc Res 73 2007 470 480
4. R. Virmani, A.P. Burke, F.D. Kolodgie, and A. Farb Vulnerable plaque: the pathology of unstable coronary lesions J Interv Cardiol 15 2002 439 446
5. H. Ichijo, E. Nishida, K. Irie, P. ten Dijke, M. Saitoh, and T. Moriguchi Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways Science 275 1997 90 94
6. T. Hayakawa, A. Matsuzawa, T. Noguchi, K. Takeda, and H. Ichijo The ASK1-MAP kinase pathways in immune and stress responses Microbes Infect 8 2006 1098 1107
7. H. Ichijo From receptors to stress-activated MAP kinases Oncogene 18 1999 6087 6093
8. Y. Izumiya, S. Kim, Y. Izumi, K. Yoshida, M. Yoshiyama, and A. Matsuzawa Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling Circ Res 93 2003 874 883
9. Y. Izumi, S. Kim, M. Yoshiyama, Y. Izumiya, K. Yoshida, and A. Matsuzawa Activation of apoptosis signal-regulating kinase 1 in injured artery and its critical role in neointimal hyperplasia Circulation 108 2003 2812 2818
10. Y. Izumi, S. Kim-Mitsuyama, M. Yoshiyama, T. Omura, M. Shiota, and A. Matsuzawa Important role of apoptosis signal-regulating kinase 1 in ischemia-induced angiogenesis Arterioscler Thromb Vasc Biol 25 2005 1877 1883
11. M. Sarai, D. Hartung, A. Petrov, J. Zhou, N. Narula, and L. Hofstra Broad and specific caspase inhibitor-induced acute repression of apoptosis in atherosclerotic lesions evaluated by radio labeled annexin A5 imaging J Am Coll Cardiol 50 2007 2305 2312
12. A. Matsuzawa, and H. Ichijo Redox control of cell fate by MAP kinase: physiological roles of ASK1-MAP kinase pathway in stress signaling Biochim Biophys Acta 1780 2008 1325 1336
13. P. Collin-Osdoby Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin Circ Res 95 2004 1046 1057
14. P. Collin-Osdoby, L. Rothe, F. Anderson, M. Nelson, W. Maloney, and P. Osdoby Receptor activator of NF-κB and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis J Biol Chem 276 2001 20659 20672
15. Committee for the Asymptomatic Carotid Atherosclerosis Study Endarterectomy for asymptomatic carotid artery stenosis JAMA 273 1995 1421 1428
16. North American Symptomatic Carotid Endarterectomy Trial Collaborators Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis N Engl J Med 325 1991 445 453
17. European Carotid Surgery Trialists Collaborative Group Medical Research Council European Carotid Surgery Trial: Randomized trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST) Lancet 351 1998 1379 1387
18. A. Luque, M. Turu, O. Juan-Babot, P. Cardona, A. Font, and A. Carvajal Overexpression of hypoxia/inflammatory markers in atherosclerotic carotid plaques Front Biosci 13 2008 6483 6490
19. A. Vink, A.H. Schoneveld, D. Lamers, A.J. Houben, P. van der Groep, and P.J. van Diest HIF-1 alpha expression is associated with an atheromatous inflammatory plaque phenotype and upregulated in activated macrophages Atherosclerosis 195 2007 e69 e75
20. M. Slevin, A.B. Elasbali, M. Miguel Turu, J. Krupinski, L. Badimon, and J. Gaffney Identification of differential protein expression associated with development of unstable human carotid plaques Am J Pathol 168 2006 1004 1021
21. Z.H. Lee, K. Kwack, K.K. Kim, S.H. Lee, and H.H. Kim Activation of c-Jun N-terminal kinase and activator protein 1 by receptor activator of nuclear factor κB Mol Pharmacol 58 2000 1536 1545
22. M. Schoppet, A.M. Sattler, J.R. Schaefer, M. Herzum, B. Maisch, and L.C. Hofbauer Increased osteoprotegerin serum levels in men with coronary artery disease J Clin Endocrinol Metab 88 2003 1024 1028
23. S. Jono, Y. Ikari, A. Shioi, K. Mori, T. Miki, and K. Hara Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease Circulation 106 2002 1192 1194
24. A. Crisafulli, A. Micari, D. Altavilla, F. Saporito, A. Sardella, and M. Passaniti Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarction Clin Sci (Lond) 109 2005 389 395
25. F. Montecucco, S. Steffens, and F. Mach The immune response is involved in atherosclerotic plaque calcification: could the RANKL/RANK/OPG system be a marker of plaque instability? Clin Dev Immunol 2007 2007 75805